The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetically engineered T-cell therapy for HPV-associated epithelial cancers: A first in human, phase I/II clinical trial.
 
Stacey L. Doran
No Relationships to Disclose
 
Sanja Stevanovic
Patents, Royalties, Other Intellectual Property - NIH/NCI; NIH/NCI (Inst)
 
Sabina Adhikary
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Jared J. Gartner
No Relationships to Disclose
 
Li Jia
No Relationships to Disclose
 
Mei Li M. Kwong
No Relationships to Disclose
 
William C Faquin
No Relationships to Disclose
 
Steven Feldman
Patents, Royalties, Other Intellectual Property - Patents 1) isolation of MAGE-A3 specific TCRs (commercial license from NIH OTT) 2) Manufacture of CAR-T cells (commercial license from NIH OTT by KITE Pharma)
 
Robert Somerville
No Relationships to Disclose
 
Richard Mark Sherry
No Relationships to Disclose
 
James C. Yang
No Relationships to Disclose
 
Steven A. Rosenberg
Research Funding - Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Kite, a Gilead company (Inst)
 
Christian S. Hinrichs
Employment - MedImmune (I)
Research Funding - Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Patents in the field of cell therapy that are held by the NIH.; Royalties from patents that are held by the NIH.